Bionic Pharma Limited - Due diligence report

A 360° intelligence report on Bionic Pharma Limited: trust score, financial health, credit view, compliance, directors, growth and distress …

2002-07-01 New Delhi, Delhi Strike Off Unlisted
Share
Connect MCP
BP Bionic Pharma Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Bionic Pharma Limited — 360° Intelligence Report

Generated from MCA filings & public records
54/100
Trust Score
Moderate

Bionic Pharma Limited is assessed as Moderate with a Trust Score of 54/100. Bionic Pharma Limited is a public limited indian non-government company incorporated in 2002, operating in the Chemicals sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a high compliance risk and an unassessed financial risk profile.

Report generated on 10 Oct 2026 from the latest processed filings. Bionic Pharma Limited snapshot & full profile →

Financial Health › No Data
Overall Assessment CautionWeakNeutralGoodStrong Neutral
Compliance › Neutral

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
54/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
45/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreNo Data
N/A
No processed financial statements available yet.
Credit Risk ScoreNo Data
N/A
Financial statements needed for a credit view.
Director Stability ScoreCaution Indicated
25/100
No active directors on record.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

No processed financials
Financial statements are not yet processed for this company. Trend analysis will appear once filings are available.
04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: N/A No Data
  • Financial statements needed for a credit view.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 45/100 Caution Indicated
  • Company status is "Strike Off" - not Active.
  • No balance-sheet filing date on record.
05

Director Intelligence

Stability score: 25/100
No active directors on record.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 65
Growth signals & trust indicators
Operating for 24+ years.
Financials unavailable - score leans on compliance and governance signals.
Distress signals & risk flags
Adverse company status: Strike Off.
Compliance score is weak (45/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence54/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • No financials on record - ask for audited statements.
Banker assessment20/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • No filed financials - rely on banking statements and GST data.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view34/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Request management accounts - public filings insufficient.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 1 events
01 Jul 2002
Incorporated
Registered with Roc Delhi
10

Key Observations

Auto-generated from the data above
Not enough data yet to generate observations.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
BREWSOME LLP AAY-3032 West Delhi, Delhi
Elite Technofin Consultants Private Limited U74140DL2008PTC176876 Delhi
Divine Light Housekeeping And Security Services Private Limited U74999DL2023PTC409412 Delhi
Sun Hydraulics Private Limited U74999DL2002PTC117315 Delhi
Digibiz Global Resource Management Private Limited U74999DL2022PTC402241 Delhi
Bhiku Ram Jain Estates Private Limited U45400DL2007PTC166515 Delhi
Mm Interra Technologies Private Limited U72900DL2019PTC358274 Delhi
Future Pet Private Limited U45200DL2011PTC216112 Delhi
Ic Environment Protection And Anti Corruption Foundation U93090DL2020NPL366827 Delhi
A K L R & CO LLP AAK-5155 West Delhi, Delhi
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Bionic Pharma Limited before audits and certifications: compliance score 45/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Bionic Pharma Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Bionic Pharma Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 54/100, distress signals and MSME payment-delay disclosures - know whether Bionic Pharma Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Bionic Pharma Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Bionic Pharma Limited an active company?

Bionic Pharma Limited has MCA status “Strike Off” with a compliance score of 45/100 (Caution Indicated).

Is Bionic Pharma Limited financially healthy?

Processed financial statements are not yet available for Bionic Pharma Limited, so its financial health is unassessed.

Should I do business with Bionic Pharma Limited?

Its overall Trust Score is 54/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Bionic Pharma Limited?

See the directors and ownership sections above for board and shareholding detail.

Does Bionic Pharma Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Bionic Pharma Limited up to date with its ROC filings?

No balance-sheet filing date on record. Overall compliance score: 45/100 (Caution Indicated).

Is it risky to lend to Bionic Pharma Limited?

Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.